Patritumab deruxtecan in untreated hormone receptor-positive/HER2-negative early breast cancer: final results from part A of the window-of-opportunity SOLTI TOT-HER3 pre-operative study
Oliveira, M., Falato, C., Cejalvo, J.M., Vila, M. Margelí, Tolosa, P., Salvador-Bofill, F.J., Cruz, J., Arumi, M., Luna, A.M., Guerra, J.A., Vidal, M., Martínez-Sáez, O., Paré, L., González-Farré, B., Sanfeliu, E., Ciruelos, E., Espinosa-Bravo, M., Pernas, S., Izarzugaza, Y., Esker, S., Fan, P.-D., Parul, P., Santhanagopal, A., Sellami, D., Villacampa, G., Ferrero-Cafiero, J.M., Pascual, T., Prat, A.
Published in Annals of oncology (01.08.2023)
Published in Annals of oncology (01.08.2023)
Get full text
Journal Article
A predictive model of pathologic response based on tumor cellularity and tumor-infiltrating lymphocytes (CelTIL) in HER2-positive breast cancer treated with chemo-free dual HER2 blockade
Nuciforo, P., Pascual, T., Cortés, J., Llombart-Cussac, A., Fasani, R., Paré, L., Oliveira, M., Galvan, P., Martínez, N., Bermejo, B., Vidal, M., Pernas, S., López, R., Muñoz, M., Garau, I., Manso, L., Alarcón, J., Martínez, E., Rodrik-Outmezguine, V., Brase, J.C., Villagrasa, P., Prat, A., Holgado, E.
Published in Annals of oncology (01.01.2018)
Published in Annals of oncology (01.01.2018)
Get full text
Journal Article
Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types
Paré, L., Pascual, T., Seguí, E., Teixidó, C., Gonzalez-Cao, M., Galván, P., Rodríguez, A., González, B., Cuatrecasas, M., Pineda, E., Torné, A., Crespo, G., Martin-Algarra, S., Pérez-Ruiz, E., Reig, Ò, Viladot, M., Font, C., Adamo, B., Vidal, M., Gaba, L., Muñoz, M., Victoria, I., Ruiz, G., Viñolas, N., Mellado, B., Maurel, J., Garcia-Corbacho, J., Molina-Vila, M Á, Juan, M., Llovet, J.M., Reguart, N., Arance, A., Prat, A.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer
Griguolo, G, Serna, G, Pascual, T, Fasani, R, Guardia, X, Chic, N, Paré, L, Pernas, S, Muñoz, M, Oliveira, M, Vidal, M, Llombart-Cussac, A, Cortés, J, Galván, P, Bermejo, B, Martínez, N, López, R, Morales, S, Garau, I, Manso, L, Alarcón, J, Martínez, E, Villagrasa, P, Prat, A, Nuciforo, P
Published in NPJ precision oncology (19.03.2021)
Published in NPJ precision oncology (19.03.2021)
Get full text
Journal Article
Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer
Villacampa, G., Tung, N.M., Pernas, S., Paré, L., Bueno-Muiño, C., Echavarría, I., López-Tarruella, S., Roche-Molina, M., del Monte-Millán, M., Marín-Aguilera, M., Brasó-Maristany, F., Waks, A.G., Pascual, T., Martínez-Sáez, O., Vivancos, A., Conte, P.F., Guarneri, V., Vittoria Dieci, M., Griguolo, G., Cortés, J., Llombart-Cussac, A., Muñoz, M., Vidal, M., Adamo, B., Wolff, A.C., DeMichele, A., Villagrasa, P., Parker, J.S., Perou, C.M., Fernandez-Martinez, A., Carey, L.A., Mittendorf, E.A., Martín, M., Prat, A., Tolaney, S.M.
Published in Annals of oncology (01.09.2023)
Published in Annals of oncology (01.09.2023)
Get full text
Journal Article
Prognostic value of intrinsic subtypes in hormone-receptor-positive metastatic breast cancer: systematic review and meta-analysis
Schettini, F., Martínez-Sáez, O., Falato, C., De Santo, I., Conte, B., Garcia-Fructuoso, I., Gomez-Bravo, R., Seguí, E., Chic, N., Brasó-Maristany, F., Paré, L., Vidal, M., Adamo, B., Muñoz, M., Pascual, T., Ciruelos, E., Perou, C.M., Carey, L.A., Prat, A.
Published in ESMO open (01.06.2023)
Published in ESMO open (01.06.2023)
Get full text
Journal Article
Residual malaria transmission: Magnitude and drivers of persistent Plasmodium infections despite high coverage of control interventions in Burkina Faso, West Africa
Namountougou, M, Kientega, M, Kaboré, PDA, Soma, DD, Pare Toe, L, Sawadogo, JME, Birba, WJ, Gnankiné, O, Dabiré, KR, Okumu, F, Diabaté, A
Published in Acta tropica (01.06.2023)
Published in Acta tropica (01.06.2023)
Get full text
Journal Article
Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration
Fernandez-Rozadilla, C, Cazier, J B, Moreno, V, Crous-Bou, M, Guinó, E, Durán, G, Lamas, M J, López, R, Candamio, S, Gallardo, E, Paré, L, Baiget, M, Páez, D, López-Fernández, L A, Cortejoso, L, García, M I, Bujanda, L, González, D, Gonzalo, V, Rodrigo, L, Reñé, J M, Jover, R, Brea-Fernández, A, Andreu, M, Bessa, X, Llor, X, Xicola, R, Palles, C, Tomlinson, I, Castellví-Bel, S, Castells, A, Ruiz-Ponte, C, Carracedo, A
Published in The pharmacogenomics journal (01.06.2013)
Published in The pharmacogenomics journal (01.06.2013)
Get full text
Journal Article
Anti-proliferative effect of oral metronomic vinorelbine in PAM50 Luminal/HER2-negative early breast cancer (SOLTI-1501 VENTANA): An open-label, randomized, three-arm, multicenter, window-of-opportunity study
Prat, A., Adamo, B., Perez Fidalgo, J.A., Blanch, S., Martinez, N., Gomez Pardo, P., López González, A., Murillo Juso, L., Amillano, K., Vidal, M., Pascual, T., Pare, L., Canes, J., Galvan, P., Gonzalez Farre, B., Ortega Cebrian, V., Gonzalez, X., Bellet Ezquerra, M., Villagrasa, P., Ciruelos, E.M.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Intergenic polymorphisms in the amphiregulin gene region as biomarkers in metastatic colorectal cancer patients treated with anti-EGFR plus irinotecan
Sebio, A, Páez, D, Salazar, J, Berenguer-Llergo, A, Paré-Brunet, L, Lasa, A, Del Río, E, Tobeña, M, Martín-Richard, M, Baiget, M, Barnadas, A
Published in The pharmacogenomics journal (01.06.2014)
Published in The pharmacogenomics journal (01.06.2014)
Get full text
Journal Article
Analytical validation of HER2DX genomic test for early-stage HER2-positive breast cancer
Marín-Aguilera, M., Jares, P., Sanfeliu, E., Villacampa, G., Hernández-lllán, E., Martínez-Puchol, A.I., Shankar, S., González-Farré, B., Waks, A.G., Brasó-Maristany, F., Pardo, F., Manning, D.K., Abery, J.A., Curaba, J., Moon, L., Gordon, O., Galván, P., Wachirakantapong, P., Castillo, O., Nee, C.M., Blasco, P., Senevirathne, T.H., Sirenko, V., Martínez-Sáez, O., Aguirre, A., Krop, I.E., Li, Z., Spellman, P., Metzger Filho, O., Polyak, K., Michaels, P., Puig-Butillé, J.A., Vivancos, A., Matito, J., Buckingham, W., Perou, C.M., Villagrasa-González, P., Prat, A., Parker, J.S., Paré, L.
Published in ESMO open (01.03.2024)
Published in ESMO open (01.03.2024)
Get full text
Journal Article
Integrated evaluation of PAM50 subtypes and immune modulation of pCR in HER2-positive breast cancer patients treated with chemotherapy and HER2-targeted agents in the CherLOB trial
Dieci, M.V., Prat, A., Tagliafico, E., Paré, L., Ficarra, G., Bisagni, G., Piacentini, F., Generali, D.G., Conte, P., Guarneri, V.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
A genotype-directed phase I-IV dose-finding study of irinotecan in combination with fluorouracil leucovorin as first-line treatment in advanced colorectal cancer
MARCUELLO, E, PAEZ, D, PARE, L, SALAZAR, J, SEBIO, A, DEL RIO, E, BAIGET, M
Published in British journal of cancer (28.06.2011)
Published in British journal of cancer (28.06.2011)
Get full text
Journal Article
De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2-week letrozole: results of the PerELISA neoadjuvant study
Guarneri, V., Dieci, M.V., Bisagni, G., Frassoldati, A., Bianchi, G.V., De Salvo, G.L., Orvieto, E., Urso, L., Pascual, T., Paré, L., Galván, P., Ambroggi, M., Giorgi, C.A., Moretti, G., Griguolo, G., Vicini, R., Prat, A., Conte, P.F.
Published in Annals of oncology (01.06.2019)
Published in Annals of oncology (01.06.2019)
Get full text
Journal Article
Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin 5-fluorouracil as first-line chemotherapy
PARE, L, MARCUELLO, E, ALTES, A, DEL RIO, E, SEDANO, L, SALAZAR, J, CORTES, A, BARNADAS, A, BAIGET, M
Published in British journal of cancer (07.10.2008)
Published in British journal of cancer (07.10.2008)
Get full text
Journal Article
Impact of CYP2D6 polymorphisms in tamoxifen adjuvant breast cancer treatment
Ramón y Cajal, T, Altés, A, Paré, L, del Rio, E, Alonso, C, Barnadas, A, Baiget, M
Published in Breast cancer research and treatment (01.01.2010)
Published in Breast cancer research and treatment (01.01.2010)
Get full text
Journal Article
A simple, field-applicable method to increase the infectivity of wild isolates of Plasmodium falciparum to mosquito vectors
Ouattara, Seydou Bienvenu, Hien, Domonbabele F D S, Nao, Ekôbié T, Paré, Prisca S L, Guissou, Edwige, Cohuet, Anna, Morlais, Isabelle, Yerbanga, Rakiswendé S, Dabiré, Kounbobr R, Ouédraogo, Jean Bosco, Mouline, Karine, Lefèvre, Thierry
Published in Malaria journal (06.05.2024)
Published in Malaria journal (06.05.2024)
Get full text
Journal Article
Natural plant diet impacts phenotypic expression of pyrethroid resistance in Anopheles mosquitoes
Paré, Prisca S L, Hien, Domonbabele F D S, Bayili, Koama, Yerbanga, Rakiswendé S, Cohuet, Anna, Carrasco, David, Guissou, Edwige, Gouagna, Louis-Clément, Yaméogo, Koudraogo B, Diabaté, Abdoulaye, Ignell, Rickard, Dabiré, Roch K, Lefèvre, Thierry, Gnankiné, Olivier
Published in Scientific reports (12.12.2022)
Published in Scientific reports (12.12.2022)
Get full text
Journal Article
Using an antimalarial in mosquitoes overcomes Anopheles and Plasmodium resistance to malaria control strategies
Paton, Douglas G, Probst, Alexandra S, Ma, Erica, Adams, Kelsey L, Shaw, W Robert, Singh, Naresh, Bopp, Selina, Volkman, Sarah K, Hien, Domombele F S, Paré, Prislaure S L, Yerbanga, Rakiswendé S, Diabaté, Abdoullaye, Dabiré, Roch K, Lefèvre, Thierry, Wirth, Dyann F, Catteruccia, Flaminia
Published in PLoS pathogens (01.06.2022)
Published in PLoS pathogens (01.06.2022)
Get full text
Journal Article
Identification of cell surface targets for CAR-T cell therapies and antibody–drug conjugates in breast cancer
Schettini, F., Barbao, P., Brasó-Maristany, F., Galván, P., Martínez, D., Paré, L., De Placido, S., Prat, A., Guedan, S.
Published in ESMO open (01.06.2021)
Published in ESMO open (01.06.2021)
Get full text
Journal Article